Sponsor Deadline
Posted: 3/8/2022

Notice of Special Interest (NOSI): Administrative Supplements for NCI Division of Cancer Biology Research Programs

The Division of Cancer Biology (DCB) at the National Cancer Institute (NCI) announces the opportunity for current Physical Sciences-Oncology Network (PS-ON), Cancer Tissue Engineering Collaborative (TEC), Cancer Systems Biology Consortium (CSBC), Patient-Derived Models of Cancer (PDMC), Metastasis Research Network (MetNet), and Cellular Cancer Biology Imaging Resource (CCBIR) awardees to apply for supplemental funding to support collaborative research projects. Collaborations can include investigators within one consortium, across consortia, or may include investigators who are not currently supported by the DCB research programs listed above. Collaborative projects must include at least one investigator not named as key personnel on the parent award. The proposed research plan must be within the overall scope of the active parent U54, U01, R37 and/or R01 award. All potential applicants are highly encouraged to contact their NCI Program Director to discuss the planned collaboration and application.

  • All requests, regardless of parent award funding mechanism, must be received by 5:00 PM local time on April 28, 2022.
  • This is a one-time announcement. Late applications will not be accepted.


Amount Description